Ongoing Clinical Trials

The Regional Nephrology Unit staff also participate in multi-centre clinical trials with current studies on erythropoiesis stimulating agents and intravenous iron for renal anaemia; tolvaptan for polycystic kidneys and statins in chronic kidney disease. We have recruited patients to high profile clinical nephrology trials such as CREATE, ASTRAL, AURORA and SHARP.